Need Help?
1-877-236-7016
Looking to speak with physicians who are currently treating multiple myeloma in europe. The discussion will be on the end-user perspective on the use of velcade, ninlaro and daratumumab. Compensation offered.
James |President & CEO
sorry cannot help with multiple myeloma...
2.6 Hours LaterYevgen |Scientific Director
Hello. In our clinic we are using Velcade, Ninlaro and *****...
16.5 Hours LaterNeed insight on takeda's ninlaro for multiple myeloma, in terms of pricing, commercialization and licensing strategies within the global multiple myeloma market space. How does it compare to velcade and amgen's kyprolis? Prefer to speak with ex-employees of takeda or someone with key insight into this specific drug in the multiple myeloma market.
Jaime |Full time Researcher Principal Investiga
I do not work for Takeda but would be happy to make the analysis. What sort of ***** you...
2 Days LaterTijana |Pharmaceutical Consultant
I am happy to help with this. Regards...
2.2 Days LaterNeel |Consultant
I am a board certified ***** oncologist that has done research in myeloma and *****...
2.4 Days LaterNeed to speak with physicians who are currently administering any of the following drugs to treat multiple myeloma in their patients - velcade -ninlaro -daratumumab (darzalex) please message me if you are a physician administering the treatment or an expert regarding the commercialization of these drugs. Compensation offered. Referrals are also welcome.
Brad |Consultant
Hi, I am a reimbursement expert familiar in the ***** these drugs and *****...
9.6 Hours LaterAleksandar |Oncology Consultant
A MD, PhD, a medical oncologist who works more than 17 years in this field in one of the most recogn...
12.9 Hours LaterYevgen |Scientific Director
Hello. In our medical center we are using this drugs. (*****) I can send ans...
13.2 Hours LaterMy name is kathleen ***** and ii am doing a project for school with a topic of chemotherapy. Our teacher wants us to find a mentor who can give us information.
Philip |Associate Director
Hi, I'm a PhD research scientist and former faculty member at MD Anderson Cancer Center. I've worke...
7.2 Hours LaterWe would like to speak with physicians ( hematologist-oncologists, immunologists, and infectious disease specialists) involved in the diagnosis, treatment, and ongoing management of patients with sid that is associated with chronic lymphocytic leukemia (cll), multiple myeloma (mm), or non-hodgkin’s lymphoma (nhl). We are aiming to carry out message testing to identify messages that are most compelling to physicians with respect to the diagnosis and treatment of secondary immune deficiency (sid) associated with hematological cancers. This is a 75-minutes paid phone consultation and a 10 minutes pre-task. If open to participating, please provide a brief answer to the screener below: 1. Do you see at least 10 patients per month with secondary immunodeficiency (sid) associated with chronic lymphocytic leukemia (cll), multiple myeloma, or non-hodgkin’s lymphoma (nhl)? Please note that we are only interested in your personal point of view and are not seeking confidential information. Referrals are highly appreciated
Mart |Marketing Director SPECT Europe
Sorry no real *****, I'm not a physician and not in any way involved in ***** CLL. There...
16 Hours LaterVICTOR |Zintro Expert
Thanks for asking for insights on this subject ***** confirm my availability for this consult...
16.5 Hours LaterAlessandro |Healthcare Manager
I am not a physician but I have experience as biologist/***** payer....
17.1 Hours LaterOur firm requires multiple professionals with knowledge on non-hodgkin lymphoma (nhl) treatment. More specifically cd3xcd20 bi-specifics, car t-cell therapy, gen3013, mosunetuzumab and similar. The ideal experts has technical/operational experience in the biotech/pharma space related to nhl treatment. As a token of thanks for your participation on an hour call, we will send $250 usd by paypal or gift card. An additional $150 is also available for successful referrals (completed call.) please note that we are not seeking confidential information. Thank you. Can you participate or refer? Please briefly (1-3 sentences perhaps) summarize your relevant experience.
Emilie T.E. |Director & Scientific Liaison
My PhD in immuno-oncology therapeutic management of NHL and B Chronic Lymphocytic Leukemia with the ...
1.1 Hours LaterAlasdair |Senior Scientist
Hello, I am an experienced consultant and have worked in the antibody field since 2004. I have spe...
9.2 Hours LaterLior |Zintro Expert
Tumour immunologist with >20 years of industrial experience in taking mAb and vaccines from ideas to...
9.3 Hours LaterWe are looking for experts in "pancreatic cancer drug development" to provide commentary and insights towards a company that has developed a chemical entity that targets the cancer cells in the primary tumors by augmenting current chemotherapy agents, reversing the chemotherapy resistance, and also targets the cancer cells with the potential for metastasis. We are an angel investing platform dedicated to connecting deep-tech startups with angel investors. By deep-tech we mean startups founded on scientific breakthroughs and technological innovations that create lasting impact on mankind. As a participating expert* in this process, your involvement is limited to answering anywhere between 8-12 investor-submitted questions. This takes about 1 hour (+/-) . Once you are vetted, we send those questions via a web form for your responses. If your contribution is published, it will be view-able by potential investors in this startup, giving you an opportunity to make connections, socialize virtually, and gain bragging rights in a vibrant entrepreneurial and angel investing community. *at this point, we cannot guarantee any monetary reimbursement. You do get insights to new upcoming technologies in your field and a tremendous networking opportunity!
Horia |Clinical Research Scientist
I am interested in the drug development and I have extensive experience in *****er researc...
6.8 Hours LaterJaime |Full time Researcher Principal Investiga
Yes I would be very glad to ***** you in this project. I look forward to hearing of ac...
7.8 Hours LaterBrad |Consultant
Hi, I would be able to provide insight. ...
8.3 Hours LaterThe zintro blog needs you! i am looking for your expert opinion on the news below and a written response that is one to three paragraphs long. Your response may be used in an article that i will write and post on the zintro site. You will be named in the article and a link to your expert profile will be included. Your contribution is voluntary (there is no direct payment involved, but you will get lots of traffic to your expert profile). If interested, please send me your response via znotes within the next one or two days. Following previous research, which showed that caffeine interferes with processes in cancer cells that control dna repair, researchers from the university of alberta are looking for new ways to take advantage of caffeineâs lethal effects on cancer cells. Do you think caffeine will be effective on chemotherapy treatment and help scientists develop targeted treatments for cancers with specific genetic changes? This is a great marketing opportunity to get your name and expert opinion published on our blog. Here is a sample: http://blog.Zintro.Com/2012/01/16/keystone-xl-pipeline-pros-and-cons/ please include your full name, we will link it to your expert profile, getting you more presence on zintro. If you have any questions, please let me know. Thank you! idil kan
Torik |Staff Scientist
This sounds like pretty ridiculous. Decades of research have not shown unambiguous effects of caffei...
2.4 Hours LaterMichael J |Professor and Senior Scientist
Dr. Michael J Gonzalez professor and senior researcher at the University of Puerto Rico Medical Scie...
3.8 Hours LaterRita |Principle
I would be happy to provide you my opinion. Please clarify how to do this, as it will be the first t...
17 Hours LaterNeed insight on janssen’s darzalex or daratumumab (dara), in terms of pricing, commercialization and licensing strategies within the multiple myeloma market space. Prefer to speak with ex-employees of janssen or someone with key insight into this specific drug in the multiple myeloma market.
Dhiraj |Head Clinical Research & Development
I am medial oncologist by training and working in field of clinical research. I have never used this...
2.6 Hours LaterLaura |Director of Biobanking Logistics and Qua
I would love to work on this project due to my MM experience...
3.1 Hours LaterDr Venkat |Global Consultant
I can refer my senior colleague who worked with J&J for very log time ...
6.6 Hours LaterConvection-enhanced delivery of cancer chemotherapy seeking experts for consulting opportunity re: devices for convection-enhanced delivery of chemo-therapies to treat tumors. Description: - seeking subject matter experts (smes) to assess novel intellectual property (ip) in the above field, and determine its commercial viability (i.E., licensing, new products/services, and/or start-up opportunities). - assessment will require approximately 2-3 hours; work will be online and telephone. Qualifications: bachelors degree, minimum 10 years in the field, with deep understanding of convection-enhanced delivery of cancer chemotherapies, with emphasis on devices and delivery methods. Areas of expertise: looking for smes with strong rd/technical background, with a preference for smes with direct experience in product development and commercialization in the field, including entrepreneurial experience. Areas of expertise: seeking experts with knowledge of cancer treatment delivery devices; convection-enhanced delivery of cancer therapies
M |Consultant/Advisor
I would be happy to comment on intellectual property around convection-enhanced chemotherapy. I am a...
1.1 Hours LaterJoanne |CEO
I would be happy to help you with this consultation. I have been in Oncology since 1992....
1.2 Hours LaterDouglas |Director/Principal Consultant
While working at Medtronic for 5 years, I was the lead scientist or lead an engineering group focuse...
7.2 Hours LaterTo evaluate the ability of miraculin (found in miracle berries) to correct chemotherapy related taste disturbances in cancer patients.
Gary |CEO
I would be glad to have a *****t your need to conduct this ***** have conducted...
1.4 Hours LaterKarim |Clinical Research Consultant
Could you please send me more detail about your need. Thanks,...
2.5 Hours LaterAdrian |Scientist
If you still need help with this, feel free to contact me....
2.9 Hours LaterWe are looking for partners in financing ongoing oncology project specialized on liposomal chemotherapy drugs - the first of which has been already granted orphan drug status by ema with ongoing registrational phase iv clinical trials in lung cancer
Floyd |Chief Pathologist
I have surpervised oncology clinical trials in the past (including an orphan drug trial) and now am ...
3.9 Hours LaterLen |Owner
Are you looking for a financial partner or someone to manage the process?...
2.2 Days LaterMuhammad Zeeshan |Project Manager
Hi i am a doctor working in oncology division of a pharma company. i can provide oncology *****...
5.1 Days LaterCyclophosphamide is a prescription medicine that is licensed to treat certain kidney problems in children and various types of cancer. A few of the types of cancer that it may be used to treat include leukemia, ovarian cancer, and lymphomas. The medicine works by cross-linking DNA cells and suppressing the immune system. It is available in both tablet and injection forms. Side effects may include hair loss, loss of appetite, and mouth sores.
Why have Zintro help with your Cyclophosphamide (cytoxan) For Cancer project? Posting only takes a few seconds and doesn't cost you anything. Typically, you will get 6-12 responses to a post from experts / vendors interested in working on your Cyclophosphamide (cytoxan) For Cancer project. Finally, you will be able to see experts/vendors' ratings, ask qualifying questions, and decide whether you want to hire them for a consultation.